Rapid hydrogel-based phage susceptibility test for pathogenic bacteria

Sheetal Patpatia1, Eric Schaedig1, Anna Dirks1

  • 1Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Insights

This study developed a rapid hydrogel-based phage susceptibility assay (PST) for personalized phage therapy. GrowDex hydrogel and specific stabilizers enable quick phage selection against antibiotic-resistant bacteria within hours.

Area of Science:

  • Microbiology
  • Biotechnology
  • Infectious Diseases

Background:

  • Antibiotic resistance necessitates alternative treatments like phage therapy.
  • Phage therapy requires selecting specific phages due to their narrow host range.
  • Rapid phage selection is crucial for effective personalized phage therapy.

Purpose of the Study:

  • To develop a rapid hydrogel-based liquid phage susceptibility assay (PST).
  • To establish a "ready-to-screen" plate concept for phage storage.
  • To optimize PST for different bacterial strains and phages.

Main Methods:

  • Tested four hydrogels (GrowDex, Askina, Purilon, Intrasite) as phage matrices.
  • Optimized PST using GrowDex with 23 bacterial strains and 23 phages.
  • Evaluated chemical stabilizers (trehalose, hyaluronic acid, gelatin) for phage stability over six months.

Main Results:

  • GrowDex hydrogel proved optimal for PST, showing no bacterial inhibition and good phage release/viability.
  • Microscopy-based PST yielded results in 3 hours without pre-culturing; OD-based PST took 5 hours with pre-culturing.
  • Gelatin and hyaluronic acid effectively stabilized phages for at least six months in liquid storage.

Conclusions:

  • A rapid, hydrogel-based PST using GrowDex is feasible for selecting therapeutic phages.
  • The "ready-to-screen" plate concept with stabilizers enhances phage therapy readiness.
  • Optimized PST protocols significantly reduce assay time, facilitating personalized treatment approaches.